| Patient | Martha Canary |
|---|---|
| Date of birth | 1856-05-01 |
| Identifiers | MRN HR-NI008-SYN-TD; SSN (made up) 000-08-9532 |
| Document date | 1901-03-02 |
| Author | Ruth Ann Kessler, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing primary care for heavy daily drinking: a nonjudgmental, trauma-informed assessment, withdrawal risk and outpatient withdrawal management, thiamine, liver tests, nutrition, mood and safety, and housing, food and income. [S]
White blood cells: 6.8 10*3/uL; Hemoglobin: 12.1 g/dL; MCV: 103 fL (high); Platelets: 162 10*3/uL; Sodium: 134 mmol/L (low); Potassium: 3.3 mmol/L (low); Creatinine: 0.62 mg/dL; eGFR (CKD-EPI 1896): 113 mL/min/1.73 m²; Glucose: 78 mg/dL; Magnesium: 1.5 mg/dL (low); Phosphate: 2.4 mg/dL (low); Albumin: 3.4 g/dL (low); Total bilirubin: 1.1 mg/dL; INR: 1; AST: 96 U/L (high); ALT: 44 U/L (high); GGT: 240 U/L (high); Folate: 3.2 ng/mL (low); Vitamin B12: 410 pg/mL; PEth: 820 ng/mL (high); AUDIT: 31; PHQ-9: 14; GAD-7: 11; PC-PTSD-5: 2. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1901-03-02 | Body height | 165 | cm | S |
| 1901-03-02 | Body weight | 50 | kg | S |
| 1901-03-02 | Body mass index (BMI) [Ratio] | 18.4 | kg/m2 | S |
| 1901-03-02 | Systolic blood pressure | 146 | mm[Hg] | S |
| 1901-03-02 | Diastolic blood pressure | 92 | mm[Hg] | S |
| 1901-03-02 | Heart rate | 104 | /min | S |
| 1901-03-02 | Respiratory rate | 18 | /min | S |
| 1901-03-02 | Body temperature | 37.2 | Cel | S |
| 1901-03-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1901-03-02 | Leukocytes [#/volume] in Blood by Automated count | 6.8 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1901-03-02 | Hemoglobin [Mass/volume] in Blood | 12.1 | g/dL | 12-15.5 g/dL | Normal | S |
| 1901-03-02 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 103 | fL | 80-100 fL | High | S |
| 1901-03-02 | Platelets [#/volume] in Blood by Automated count | 162 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1901-03-02 | Sodium [Moles/volume] in Serum or Plasma | 134 | mmol/L | 135-145 mmol/L | Low | S |
| 1901-03-02 | Potassium [Moles/volume] in Serum or Plasma | 3.3 | mmol/L | 3.5-5.1 mmol/L | Low | S |
| 1901-03-02 | Creatinine [Mass/volume] in Serum or Plasma | 0.62 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1901-03-02 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1896)/1.73 sq M | 113 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1901-03-02 | Glucose [Mass/volume] in Serum or Plasma | 78 | mg/dL | 70-99 mg/dL | Normal | S |
| 1901-03-02 | Magnesium [Mass/volume] in Serum or Plasma | 1.5 | mg/dL | 1.7-2.3 mg/dL | Low | S |
| 1901-03-02 | Phosphate [Mass/volume] in Serum or Plasma | 2.4 | mg/dL | 2.5-4.5 mg/dL | Low | S |
| 1901-03-02 | Albumin [Mass/volume] in Serum or Plasma | 3.4 | g/dL | 3.5-5 g/dL | Low | S |
| 1901-03-02 | Bilirubin.total [Mass/volume] in Serum or Plasma | 1.1 | mg/dL | <=1.2 mg/dL | Normal | S |
| 1901-03-02 | INR in Platelet poor plasma by Coagulation assay | 1 | {INR} | 0.9-1.1 | Normal | S |
| 1901-03-02 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 96 | U/L | 10-35 U/L | High | S |
| 1901-03-02 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 44 | U/L | 7-35 U/L | High | S |
| 1901-03-02 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 240 | U/L | 5-40 U/L | High | S |
| 1901-03-02 | Folate [Mass/volume] in Serum or Plasma | 3.2 | ng/mL | >=4 ng/mL | Low | S |
| 1901-03-02 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 | pg/mL | 200-900 pg/mL | Normal | S |
| 1901-03-02 | Phosphatidylethanol [Mass/volume] in Blood | 820 | ng/mL | <=20 ng/mL | High | S |
| 1901-03-02 | Total score [AUDIT] | 31 | {score} | S | ||
| 1901-03-02 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 14 | {score} | S | ||
| 1901-03-02 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 11 | {score} | S | ||
| 1901-03-02 | PC-PTSD-5 score [PC-PTSD-5] | 2 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Gabapentin 300 mg oral capsule on a written five-day schedule for alcohol withdrawal: 300 mg in the morning, 300 mg in the afternoon and 600 mg at bedtime for three days, then 300 mg twice daily on day four, 300 mg at bedtime on day five, then stop; dispensed for the five days only | Per the written five-day schedule | Oral route | 1901-03-02 to 1901-03-06 | completed | S |
| Thiamine 100 mg by intramuscular injection once daily for three days, given in the clinic | 100 mg intramuscularly once daily for three days | Intramuscular route | 1901-03-02 to 1901-03-04 | completed | S |
| Folic acid 1 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1901-03-02 | active | S |
| Potassium chloride extended-release 20 mEq oral tablet, one tablet daily with food for five days | One tablet daily with food for five days | Oral route | 1901-03-02 to 1901-03-06 | completed | S |
| Magnesium oxide 400 mg oral tablet, one tablet twice daily for two weeks | One tablet twice daily for two weeks | Oral route | 1901-03-02 to 1901-03-16 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Alcohol use disorder, severe (nine of eleven DSM-5-TR criteria), daily drinking of about a pint of whiskey with heavier binges for many years; synthetic modern episode linked to her documented lifelong heavy drinking | active | confirmed | F10.20 | S — Synthetic modern coding; DSM-5-TR severe alcohol use disorder maps to F10.20 when withdrawal is coded separately. Person-first language; not a claim about her real diagnosis. |
| Alcohol withdrawal, mild, at low risk of complications (PAWSS 3, CIWA-Ar 9 at intake; no past seizures or delirium tremens), managed as an outpatient with daily nurse checks | active | confirmed | F10.230 | S — Synthetic withdrawal episode; resolved by the one-week visit. |
| Raised liver enzymes (AST 96, ALT 44, GGT 240 U/L) with a FIB-4 index of 3.93, above the cut point for possible advanced fibrosis; liver stiffness measurement planned | active | confirmed | R74.01 | S — Synthetic presenting finding; superseded when elastography and the clinical picture supported alcohol-associated steatotic liver disease. |
| Depressive symptoms during heavy drinking (PHQ-9 14, item 9 scored 0); whether they are alcohol-induced or an independent depression to be judged after two to four weeks without alcohol | active | provisional | F32.A | S — Synthetic provisional finding; resolved as the PHQ-9 fell to 5 after ten weeks without alcohol, consistent with alcohol-induced depressive symptoms. Not a claim about her real mood. |
| Daily chewing tobacco for many years; not ready to stop at intake | active | confirmed | F17.220 | S — Synthetic modern coding anchored to the documented chewing tobacco. |
| Underweight (BMI 18.4) with poor food intake, low folate, magnesium and phosphate, and slightly low albumin | active | confirmed | R63.6 | S — Synthetic finding anchored to a contemporary impression of poor nutrition (R). |
| Housing instability: staying in a spare room at a friend's house, with nowhere to go if that ends; has stayed in shelters in past winters | active | confirmed | Z59.811 | S — Synthetic social need anchored to her documented poverty and moves from town to town. |
| Food insecurity: often goes without meals at the end of the month | active | confirmed | Z59.41 | S — Synthetic social need anchored to her documented poverty. |